按首字母搜索

产品名字索引 N

• NSD1 抑制剂 BT5 (Catalog# : 25207, Cas# : 2351225-46-0)BT5可有效抑制NSD1，与细胞中的SET结构域结合，并降低H3K36me2水平。
• Nizubaglustat ( 同义词: AZ-3102 ) (Catalog# : 25175, Cas# : 1633666-49-5)Nizubaglustat（AZ-3102）是一种口服小分子，可抑制阿扎法罗斯开发的
• NT-0796 (Catalog# : 25153, Cas# : 2272917-13-0)NT-0796 是一种抑制 NLRP3 炎症小体的口服小分子。
• Nivegacetor ( 别名: RG-6289, RO-7269162) (Catalog# : 25151, Cas# : 2443487-67-8)Nivegacetor（RG-6289，RO-7269162）是一种口服γ分泌酶调节剂。
• Nedisertib ( peposertib ) (Catalog# : 25094, Cas# : 1637542-33-6)Nedisertib，也称为M-3814，MSC2490484A，是一种口服的DNA依赖性蛋白激酶
• NST-628 (Catalog# : 24058, Cas# : 3002056-30-3)NST-628 是具有血脑屏障渗透性的 MAPK 通路分子胶，能够抑制 RAF 磷
• NT219 (Catalog# : 25067, Cas# : 1198078-60-2)NT219 is a novel inhibitor of the insulin/igf signaling cascade (iis), mediating a lo
• Nanatinostat (Catalog# : 25034, Cas# : 1256448-47-1)Nanatinostat, also known as Tractinostat, CHR-3996 and VRx-3996, is an orally bioavai
• NPD-3519 (Catalog# : 24089, Cas# : 3032452-90-4)
• NDI-091143 (Catalog# : 24057, Cas# : 2375840-87-0)NDI-091143 is a novel potent inhibitor of human ATP-citrate lyase, indirectly disrupt
• NMD670 (Catalog# : 24050, Cas# : 2354321-33-6)NMD670 is an orally bioavailable skeletal muscle-specific chloride ion channel (ClC-1
• NNC-55-0396 (Catalog# : 24038, Cas# : 357400-13-6)NNC-55-0396是一种高选择性T型钙通道阻滞剂，可用于神经系统疾病研
• NVL-655 ( ALK-IN-27 ) (Catalog# : 24003, Cas# : 2739866-40-9)NVL-655是一种新型脑渗透性ALK选择性抑制剂，旨在解决目前可用的
• Navacaprant (Catalog# : 23122601, Cas# : 2244614-14-8)Navacaprant (NMRA-335140, BTRX-140) 是一种口服、选择性、可逆的 kappa 阿
• Ninerafaxstat (Catalog# : 20608, Cas# : 2254741-41-6)Ninerafaxstat is a biochemical that decreases fatty acid oxidation and improves mitoc
• NBI-921352 (Catalog# : 20602, Cas# : 2154406-04-7)NBI-921352 is a potent, highly selective Nav1.6 sodium channel inhibitor being develo
• Navitoclax-piperazine (Catalog# : 20559, Cas# : 2143096-93-7)Navitoclax-piperazine, also known as ABT-263-piperazine, is a Navitoclax derative and
• NMS-293 ( NMS-P293 ) (Catalog# : 20514, Cas# : 1606996-12-6)NMS-293 是 Nerviano Medical Sciences 处于早期临床开发阶段的 PARP-1 抑制
• NSC348884 (Catalog# : 20487, Cas# : 81624-55-7)NSC348884 is a nucleophosmin inhibitor. NSC348884 also disrupts oligomer formation an
• NSC-92828 (Catalog# : 20486, Cas# : 13728-56-8)NSC-92828, also known as 3-Phenanthrenebutyric acid, is a Protein–protein interacti
• NSC-45586 (Catalog# : 20483, Cas# : 6300-44-3)NSC-45586 is a pan-PHLPP inhibitor selective for PHLPP1 and PHLPP2.
• NXP-800 ( CCT361814 ) (Catalog# : 233141, Cas# : 1693734-80-3)NXP800 是一种口服小分子热休克因子 1 (HSF1) 通路抑制剂。 NXP800 可
• NBD-14270 (Catalog# : 20448, Cas# : 2411819-82-2)
• NXY-059 ( Disufenton Sodium ) (Catalog# : 52014, Cas# : 168021-79-2)Disufenton sodium (NXY-059) 是神经保护剂phenylbutynitrone的衍生物，具有极
• N-Benzyl-2,6-difluoro-3,5-dimethoxyaniline (Catalog# : 20411, Cas# : 651734-53-1)
• N-(6-bromo-2-ethyl-8-methylimidazo[1,2-a]pyridin-3-yl)formamide (Catalog# : 20402, Cas# : 1628263-77-3)
• N-(6-bromo-2-ethyl-8-methylimidazo[1,2-a]pyridin-3-yl)-N-methylformamide (Catalog# : 20401, Cas# : 1628263-96-6)
• N,N-DIETHYL-2,6-CIS-DIMETHYLPIPERIDINIUM IODIDE (Catalog# : G20383, Cas# : 1335241-44-5)
• Navoximod free base (Catalog# : 20290, Cas# : 1402837-78-8 (free base))
• NE 52-QQ57 (Catalog# : 21233, Cas# : 1401728-56-0)NE52-QQ57 is an orally available GPR4 antagonist with an IC50 of 70 nM. NE 52-QQ57 si